Alpine Woods Capital Investors, LLC Biogen Inc. Transaction History

Alpine Woods Capital Investors, LLC

  • $626 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 06, 2019
SELL
$216.71 - $338.96 $151,697 - $237,272
-700 Closed
0 $0
Q4 2018

Feb 13, 2019
SELL
$278.5 - $352.75 $835 - $1,058
-3 Reduced 0.43%
700 $211,000
Q3 2018

Nov 08, 2018
BUY
$293.51 - $383.83 $206,337 - $269,832
703 New
703 $248,000

Others Institutions Holding BIIB

# of Institutions
1,036
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Alpine Woods Capital Investors, LLC Portfolio

Follow Alpine Woods Capital Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email